Hunter Tony
The Salk Institute, La Jolla, CA 92037, USA.
Curr Opin Cell Biol. 2009 Apr;21(2):140-6. doi: 10.1016/j.ceb.2009.01.028. Epub 2009 Mar 9.
In the 30 years since its discovery, tyrosine phosphorylation has emerged as a fundamentally important mechanism of signal transduction and regulation in all eukaryotic cells, governing many processes, including cell proliferation, cell cycle progression, metabolic homeostasis, transcriptional activation, neural transmission, differentiation and development, and aging. Perturbations in tyrosine phosphorylation underlie many human diseases, and in particular cancer, and this has prompted the development of inhibitors of tyrosine kinases implicated in disease, a number of which have been approved for clinical use. The following is a brief personal reflection on some of the salient findings over the past 30 years that led to the development of tyrosine kinase inhibitors for disease therapy.
自酪氨酸磷酸化被发现的30年来,它已成为所有真核细胞中信号转导和调控的一种至关重要的基本机制,支配着许多过程,包括细胞增殖、细胞周期进程、代谢稳态、转录激活、神经传递、分化与发育以及衰老。酪氨酸磷酸化的紊乱是许多人类疾病尤其是癌症的基础,这促使了针对与疾病相关的酪氨酸激酶抑制剂的开发,其中一些已被批准用于临床。以下是对过去30年中一些显著发现的简要个人思考,这些发现促成了用于疾病治疗的酪氨酸激酶抑制剂的开发。